Financial News for Target Corporation (TGT)
| TGT | 1/4/2010 12:29PM | 52 Week Price Range | Market Capitalization | Dividend Yield | Recent Dividend |
|---|---|---|---|---|---|
| $48.67 | $25.00 — $51.77 | $36.4 Billion | 1.40% | $0.60 |
Want to Sharpen Your Investing?
Learn how Ockham can help investors make informed decisions and slice through the noise. Learn more about Ockham's services.
Explore Why Ockham?
Quality Analysis
Crowd Sentiment
Financial News Slicing
Target Corp. was discussed on Mad Money
which was originally produced by CNBC on 11/5/2009
Target Corporation was talked about on Mad Money, and you can see the relevant discussion below.
Names that could help big pharmaceutical companies grow again if they are acquired. Take a look at dendrean first. That develops drugs which help your immune system TARGET and attack cancer cells. It's main product is called prevenge. That's not to be confused with from mcgregor, the employer of the one-arm man and the nemesis of cramer fave dr. Richard prostate cancer drug that's in late-stage development and it could be huge.
“fused with from mcgregor, the employer of the one-arm man and the nemesis of cramer fave dr. Richard prostate cancer drug that's in late-stage development and it could be huge. ” Mad Money Nov 5, 2009 6:49 PM
Just a couple of things to take note of:
- Since this comment, TGT's stock price has declined by 0.37%.
- Please visit the Mad Money recap page for all the slices of the 27 stocks mentioned on just this one episode of the show.
- This was the only mention for Target Corporation on this show, but you can see all other stocks mentioned by Jim Cramer on Mad Money by visiting the Mad Money recap.
- Besides Target Corporation's mention on Mad Money it's also been discussed 8 times on various other business shows since then. You can also catch up on All financial news for Target Corporation.